All Articles

With a $22M Series A and a factory-focused plan, Foundation Alloy is moving to scale a melt-free metallurgy process that could redefine global manufacturing.

A new silicon battery from Coreshell promises a 30% performance boost and a domestic supply chain, aiming to secure U.S. military technology from foreign risk.

Pasithea Therapeutics is expanding its NF1 trial for PAS-004, a move that signals a deeper strategic commitment to outmaneuvering competitors and meeting a critical unmet medical need.

Tiny biotech HCW Biologics reports promising early data for its alopecia drug. But with a small sample size and big pharma rivals, is this a true breakthrough?

Insurtech firm PolicyMe has launched a unified platform promising to match any Canadian to the right life insurance in one session. Is this the innovation that finally cracks the industry's complexity, or a new tech facing a tough regulatory road?

V2 Cloud’s latest move isn’t just a tech upgrade; it’s a blueprint for how organizations can build a more equitable and productive digital workplace.

American Water's $40,000 investment in Missouri nonprofits is more than charity; it's a strategic blueprint for how essential services can build community.

At SHRM26, V2 Cloud launched an AI assistant and a performance-assured VDI, aiming to give HR leaders a secure, easy-to-use toolkit for modern work.

As AI-savvy candidates overwhelm old hiring systems, HeyMilo's new agentic platform aims to level the field. But does it solve the problem or just escalate it?

Taco Bell’s new fajita menu is more than a product launch; it's a case study in adaptation, deconstructing a classic dish for on-the-go consumers.

Strive Health's new CMO and CFO hires signal a strategic acceleration in value-based kidney care, blending clinical innovation with financial AI deployment.

As Woof Gang expands into new states, it's not just opening stores. It's executing a masterclass in market dominance within the booming pet industry.

Biotech firm ProJenX reports its novel ALS drug, prosetin, is safe and hits key targets in early trials, offering a new beacon of hope for the disease.

A new AI platform promises to slash drug development red tape. But can it overcome the industry’s deep-rooted challenges of privacy, trust, and integration?

A strategic investment in RCM provider Fellow Health Partners reveals a deeper trend: PE firms are now backing high-touch service, not just scalable tech.

With $1.17M in new funding, Metallis Resources is reviving a historic Idaho silver camp, targeting the critical mineral antimony vital for tech and defense.

A single soldier controlling a swarm of drones in a contested battle. Palladyne AI's recent test with the U.S. Army signals a major leap in autonomy.

The appointment of drug development veteran Dr. Aaron Koenig at Syremis Therapeutics is more than a new hire; it's a strategic play in the high-stakes race to redefine mental health treatment.

A major deal between Aeva and Bendix brings advanced 4D LiDAR to commercial trucking, promising enhanced safety and signaling a major shift in the ADAS industry.

As the U.S. nears its 250th birthday, a new survey reveals most Americans haven't seen key historical sites. One company is turning this gap into a business.